Weilong Chen

Senior Research Fellow at Jinfeng Laboratory, Chongqing, China;
Study breast cancer brain metastasis, cancer stem cells and tumor micro environment.

[Weilong Chen @WeilongChen3]

@QingZhangLab Excellent work!

[Weilong Chen @WeilongChen3]

@QingZhangLab Congratulations！

[Qing Zhang @QingZhangLab]

Thrilled to share our latest publication on selected degradation of TBK1 in blocking tumor progression in RCC (as well as in PDAC).
https://t.co/RruaZcPaYm

[Weilong Chen @WeilongChen3]

@QingZhangLab Congrats!!!

[Qing Zhang @QingZhangLab]

JCI - Genome-wide CRISPR screen identifies a cytokine–enhancer circuit driving HIF-2α activation in renal cancer https://t.co/LbhFHlunpm

[Faheem Ullah @Faheem_uh]

Template for writing abstract of a research paper 👇

This is shared by Nature - one of the best journals

[Science News @ScienceBriefs]

How To Remember Everything You Read

#PhD #academia #AcademicTwitter #postdoc #InnovMed2026

[Science News @ScienceBriefs]

How to write an excellent Review article
#PhD #phdlife #postdoc #Science #academia

[Journal of Clinical Investigation @jclinicalinvest]

#BreastCancer stem cells drive resistance to standard therapies in triple-negative breast cancer.

Here, @QingZhangLab @ChenghengLiao & team @UTSWNews show targeting kinesin family member KIF20A in vitro and in mice sensitizes stem-like #TNBC cells to standard chemotherapy: https://t.co/mSbZCxRdL9

[Journal of Clinical Investigation @jclinicalinvest]

@QingZhangLab @ChenghengLiao @utswnews Targeting kinesin family member 20A sensitizes stem-like triple-negative breast cancer cells to standard chemotherapy

[Weilong Chen @WeilongChen3]

In 2025, I reviewed three research papers and am looking forward to contributing more to the scientific community in the new year! #SNreviewers @SpringerNature

[Qing Zhang @QingZhangLab]

Glad to share our latest paper @jclinicalinvest on targeting KIF20A on sensitizing TNBC to chemotherapy @UTSW_Pathology @utswcancer Targeting kinesin family member 20A sensitizes stem-like triple-negative breast cancer cells to standard chemotherapy https://t.co/I8cUMwl0mg

[AACR @AACR]

Submit an abstract by December 4 for the AACR Special Conference on Innovations in Kidney Cancer Research (March 13-16; Philadelphia), chaired by Eric Jonasch, M. Celeste Simon, Samra Turajlic, and Qing Zhang. Learn more:
https://t.co/3PmWWSqTzP
#AACRkidney26 @QingZhangLab

[Qing Zhang @QingZhangLab]

Despite a series of grant rejections during this year, we are happy to share our latest publication @CD_AACR on the role of BBOX1 as a potential therapeutic target in TNBC. https://t.co/Wu7gNvSwGl
@UTSWNews @CPRITTexas 1/12

[Qing Zhang @QingZhangLab]

Happy to share our latest work @CD_AACR
on identifying TBK1 as a synthetic lethality target with VHL loss in kidney cancer @UTSWNews @utswcancer
@KCPUTSW. Thanks for the supports from @CDMRP
@kcCURE @theNCI @NCICancerBio https://t.co/AoubF6k4Eo

[Weilong Chen @WeilongChen3]

#新头像